Toxic shock syndrome due to group A streptococcal pharyngitis and bacteremia in adults

Journal of Microbiology, Immunology and Infection

Volumn 42, Issue 3, 2009, Pages 276-279

  Vucicevic, Zeljko ^a   Jajic Bencic, Ines ^a   Kruslin, Bozo ^a   Degoricija, Vesna ^a  

^a SESTRE MILOSRDNICE UNIVERSITY HOSPITAL   (Croatia)

Author keywords

Pharyngitis; Shock, septic; Streptococcus pyogenes

Indexed keywords

CLINDAMYCIN; CRYSTALLIN; DOPAMINE; SALBUTAMOL;

ACUTE KIDNEY FAILURE; ADULT; ALLERGIC ASTHMA; ARTICLE; AUTOPSY; BACTEREMIA; CASE REPORT; DISSEMINATED INTRAVASCULAR CLOTTING; HEMODIALYSIS; HEMOFILTRATION; HUMAN; MALE; STREPTOCOCCAL PHARYNGITIS; TOXIC SHOCK SYNDROME;

ANTI-BACTERIAL AGENTS; BACTEREMIA; FATAL OUTCOME; HUMANS; LUNG; MALE; PHARYNGITIS; SHOCK, SEPTIC; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES; YOUNG ADULT;

EID: 70349911954     PISSN: 16841182     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Bisno AL, Stevens DL. Streptococcal infections in skin and soft tissues. N Engl J Med. 1996;334:240-245 (Pubitemid 26030675)
2. Martin PR, Hoiby EA. Streptococcal serogroup A epidemic in Norway 1987-1988. Scand J Infect Dis. 1990;22:421-429
3. Thomas JC, Carr SJ, Fujioka K, Waterman SH. Community-acquired group A streptococcal deaths in Los Angeles County. J Infect Dis. 1989;160:1086-1087 (Pubitemid 20002786)
4. O'Brien KL, Beall B, Barrett NL, Cieslak PR, Reingold A, Farley MM, et al. Epidemiology of invasive group A Streptococcus disease in the United States, 1995-1999. Clin Infect Dis. 2002;35:268-276
5. Bullowa JGM, Wishik, SM. Complications of varicella I. Their occurrence among 2,534 patients. Am J Dis Child. 1935;49:923-926
6. Stevens DL. Invasive group A Streptococcus infections. Clin Infect Dis. 1992;14:2-13.
7. Johnson DR, Stevens DL, Kaplan EL. Epidemiologic analysis of group A streptococcal serotypes associated with severe systemic infections, rheumatic fever, or uncomplicated pharyngitis. J Infect Dis. 1992;166:374-382
8. Stevens DL. Streptococcal toxic-shock syndrome. Clin Microbiol Infect. 2002;8:133-136
9. The Working Group on Severe Streptococcal Infections. Defining the group A streptococcal toxic shock syndrome. JAMA. 1993;269:390-391
10. Barnham M. Bacteraemia in streptococcal infections of the throat. J Infect. 1983;7:203-209
11. Yan S, Bohach GA, Stevens DL. Persistent acylation of high-molecular weight penicillin binding proteins by penicillin induces the post antibiotic effect in Streptococcus pyogenes. J Infect Dis. 1994;170:609-614 (Pubitemid 24262262)
12. Zimbelman J, Palmer A, Todd J. Improved outcome of clindamycin compared with beta-lactam antibiotic treatment for invasive Streptococcus pyogenes infection. Pediatr Infect Dis J. 1999;18:1096-1100
13. Mascini EM, Jansze M, Schouls LM, Verhoef J, Van Dijk H. Penicillin and clindamycin differentially inhibit the production of pyrogenic exotoxins A and B by group A streptococci. Int J Antimicrob Agents. 2001;18:395-398 (Pubitemid 33016357)
14. Richter SS, Heilman KP, Beekman SE, Miller NJ, Miller AL, Rice CL, et al. Macrolide-resistant Streptococcus pyogenes in the United States, 2002-2003. Clin Infect Dis. 2005;41:599-608.
15. Valiquette L, Low DE, Chow R, McGeer AJ. A survey of physician's attitudes regarding management of severe group A streptococcal infections. Scand J Infect Dis. 2006;38:977-982 (Pubitemid 44869267)
16. Mehta S, McGeer A, Low DE, Hallett D, Bowman DJ, Grossman SL, et al. Morbidity and mortality of patients with invasive group A streptococcal infections admitted to the ICU. Chest. 2006;130:1679-1686 (Pubitemid 46033419)